References

Maniaci A, Lavalle S, Masiello E Platelet-rich plasma (prp) in the treatment of long COVID olfactory disorders: a comprehensive review. Biomedicines. 2024; 12:(4) https://doi.org/10.3390/biomedicines12040808

Skin barrier dysfunction drives skin inflammation via formylpeptide receptor 1. Br J Dermatol. 2024; 190:(4) https://doi.org/10.1093/bjd/ljae077

Humzah D, Molina B, Salti G, Cigni C, Bellia G, Grimolizzi F. Intradermal Injection of Hybrid Complexes of High- and Low-Molecular-Weight Hyaluronan: Where Do We Stand and Where Are We Headed in Regenerative Medicine?. Int J Mol Sci. 2024; 25:(6) https://doi.org/10.3390/ijms25063216

Semenescu I, Similie D, Diaconeasa Z, Danciu C. Recent advances in the management of rosacea through natural compounds. Pharmaceuticals (Basel). 2024; 17:(2) https://doi.org/10.3390/ph17020212

Lim TS, Liew S, Tee XJ Polynucleotides hpt for asian skin regeneration and rejuvenation. Clin Cosmet Investig Dermatol. 2024; 17:417-431 https://doi.org/10.2147/CCID.S437942

Research Roundup

02 July 2024
Volume 13 · Issue 4

Abstract

In this regular feature, aesthetic nurse Claudia McGloin presents a brief synopsis of a range of recently published articles on medical aesthetics. Research roundup aims to provide an overview, rather than a detailed summary and critique, of the papers selected. Should you wish to look at any of the papers in more detail, a full reference is provided at the end of each study summary

In the 4 years since the pandemic, long COVID has produced many challenges within healthcare. One of the most challenging is olfactory dysfunction (OD). This is a hugely distressing side effect for many patients around the world. A constant loss of smell affecting the patient which has a huge impact on their quality of life. In the last year or so, there has been much speculation on the potential outcome that platelet-rich plasma (PRP) therapy could have as a treatment for OD.

The aim of this review was to evaluate the effectiveness of PRP therapy in ameliorating OD, especially when associated with treating the long-term effects caused by COVID-19.

To conduct this study, the authors conducted a comprehensive search of any literature, studies and papers that highlighted any clinical trials or cases that showed PRP was used to treat OD. This, of course was limited to the use of PRP for COVID-19. The authors found and discussed data such as design, participant demographics, and reported outcomes, focusing on the efficacy and safety of PRP therapy for the treatment of OD in COVID-19 patients.

Register now to continue reading

Thank you for visiting Journal of Aesthetic Nurses and reading some of our peer-reviewed resources for aesthetic nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month